Clinical Trial Update: A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the safety and tolerability of regadenoson in subjects with renal impairment, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Coronary Artery Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Diseases, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2011-01-31